<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In a low-risk pregnant patient at 21 weeks' gestation, ultrasound revealed shortening of fetal long bones compatible with <z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">achondroplasia</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Funipuncture was performed and DNA analysis of fetal blood demonstrated the presence of the GR380R fibroblast growth factor receptor 3 (FGFR3), which is specifically associated with <z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">achondroplasia</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>After termination of the pregnancy, necropsy confirmed the prenatal diagnosis </plain></SENT>
<SENT sid="3" pm="."><plain>A certain sonographic diagnosis of fetal de novo <z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">achondroplasia</z:e> is rarely possible prior to viability </plain></SENT>
<SENT sid="4" pm="."><plain>The specificity of the FGFR3 causative mutation has added a new diagnostic option which can be applied prenatally for diagnostic validation </plain></SENT>
</text></document>